Quantcast
Latest Stories

Medical Files

My personal affair with melatonin

By

Many have been asking why I have been taking a melatonin supplement nightly for around 20 years now. I started taking it in the early ’90s, not because of its sleep-enhancing benefit, but for its immune-system boosting effect.

I used to have severe bouts of allergic rhinitis when I was young. It has reached a point when I thought I would have to live with it the rest of my life. It was not the seasonal type; I had it all-year round. Mornings and evenings had to be endured with teary and itchy eyes, a runny and equally itchy nose. My handkerchiefs would be soaked wet with clear mucus by mid-morning.

Several times a year, bacterial infection would superimpose on my allergic rhinitis and this would progress into upper or lower respiratory tract infection. I must have taken all sorts of antihistamines and some steroids then, but the antihistamines made me drowsy all day and so I stopped taking them. I decided I could be more functional with my runny nose and teary eyes, than my drooping eyelids.

I came upon a published study showing the immune-system-boosting effect of melatonin. Of course, its sleep-enhancing effect was already well known since then. I tried to research if there were specific studies on the effect of melatonin in allergic rhinitis but I could not find any then. I’m not sure if there are already available studies now. I have been encouraging my ENT (Ear, Nose and Throat) specialist-friends to conduct a local study.

Although there were no specific data on allergic rhinitis, it seemed to me then that if melatonin could help those with markedly suppressed immune systems, allergic rhinitis should be a walk in the park for it. So I started taking 3-mg capsules of Melatonin-T nightly. It was already available then as an over-the-counter dietary supplement in Mercury and other drugstores. Lately, I’m taking Sleepwell Melatonin, but it’s just the same preparation as Melatonin-T.

 

Better sleep

There was not much change in the first four weeks in my allergic rhinitis symptoms, except that I had better sleep. I was already tempted to discontinue it. By the second month, the severity of my allergic rhinitis gradually lessened. After four months or so, my allergic rhinitis was practically reduced to an occasional transient stuffiness of the nose on waking up. After about a year of being symptom-free, which I have never experienced in decades, I decided to see if I could already stop taking melatonin. I would be okay for a week or so, but after that, the previous symptoms would slowly recur. So since then, I decided to take it religiously every night.

I still browse the scientific literatures from time to time to check on any long-term adverse effects of melatonin since I’ve been taking it for quite a while already and planning to do so for life. I’m glad to note that there was none reported. In fact recently, many cancer centers abroad are prescribing melatonin in mega-doses (20 to 50 mg) as a beneficial anticancer supplemental therapy in patients receiving chemo- or radio-therapy for various forms of cancer.

Melatonin also been demonstrated to have anticancer properties, not only  by directly helping prevent the growth and spread of cancer cells but also by reducing the side effects, particularly bone marrow suppression, of common anticancer drugs (chemotherapy) and radiation treatments.

In highly symptomatic cancer patients, in whom the disease has already spread, melatonin has been shown to alleviate numerous cancer symptoms, and inhibit the development of new tumor blood vessels (tumor angiogenesis). This last benefit can help prevent the cancer from spreading further.

Retard tumor metabolism

One interesting finding is that melatonin can retard tumor metabolism and development by lowering the body temperature—as a natural inducer of hypothermia. Its antioxidant properties also hinder tumor cells from causing damage to normal cells. It also limits oxidative damage to cellular components caused by various anticancer treatments.

Melatonin supplementation, given at a dose of 20 mg/day, has been shown to be beneficial in the supportive care of even advanced and end-stage cancer patients by enhancing immune function; reducing tissue wasting or cachexia, weight loss, fatigue, weakness and depression; and improving quality of life and survival rate. In cancer patients requiring surgery, melatonin has also been shown to improve wound healing.

Chemotherapy-induced side effects such as anemia, lymphocytopenia and thrombocytopenia, anorexia and vomiting have been reduced. It also helps in reducing cancer pain (including bone pains).

Women with estrogen-receptor-positive breast cancer have also been shown to have low plasma melatonin levels. These women can benefit a lot from melatonin supplementation. Melatonin has been demonstrated to inhibit human breast cancer cell growth and reduce the invasiveness of breast cancer cells. Women who work night shifts like nurses and factory workers are at increased risk of developing breast cancer because of lowered melatonin levels, since the secretion of this natural hormone usually occurs at night time, stimulated by darkness.

It’s amazing what a simple substance like melatonin can produce. Aside from its sleep-enhancing and anticancer effects, it also has a lot of other health benefits which are also backed up already by scientific data.

I usually advise younger physicians not to believe any drug or product which claims to have multiple benefits. Too good to be true, I would tell the doctors. Well, I guess melatonin may be an exception.


Follow Us


Follow us on Facebook Follow on Twitter Follow on Twitter


Recent Stories:

Complete stories on our Digital Edition newsstand for tablets, netbooks and mobile phones; 14-issue free trial. About to step out? Get breaking alerts on your mobile.phone. Text ON INQ BREAKING to 4467, for Globe, Smart and Sun subscribers in the Philippines.

Tags: column , dr. Rafael Castillo , health and wellness , melatonin



Copyright © 2014, .
To subscribe to the Philippine Daily Inquirer newspaper in the Philippines, call +63 2 896-6000 for Metro Manila and Metro Cebu or email your subscription request here.
Factual errors? Contact the Philippine Daily Inquirer's day desk. Believe this article violates journalistic ethics? Contact the Inquirer's Reader's Advocate. Or write The Readers' Advocate:
c/o Philippine Daily Inquirer Chino Roces Avenue corner Yague and Mascardo Streets, Makati City, Metro Manila, Philippines Or fax nos. +63 2 8974793 to 94
Advertisement
Advertisement

News

  • Complex health care system for California’s elderly and poor explained
  • Malang the croc must regain strength before return to swamp, says mayor
  • Palace: Lacson’s version of Napoles testimony to be evaluated
  • Scientists eye iceberg bigger than Guam
  • Drilon: I’m not on Napoles’ list
  • Sports

  • Promoters Dela Hoya, Arum in talks for Pacquiao-Alvarez—report
  • Benzema guides Madrid to 1-0 win over Bayern
  • Suns’ Goran Dragic win NBA’s Most Improved Player award
  • Heat go up 2-0, hold off Bobcats 101-97
  • Ronaldo shakes off injury fears to play Bayern
  • Lifestyle

  • Gongs and southern dances star in a workshop at San Francisco Bayanihan Center
  • This woman ate what?
  • Photos explore dynamics of youths’ sexual identity
  • 12th Philippine Food Expo set at the World Trade Center
  • No tourist draw, Malang the croc will remain wild
  • Entertainment

  • Smithsonian wants photos, videos for ‘Day in the Life of Asian Pacific Americans’
  • What Garcia Marquez left behind
  • Has Ai Ai fallen deeply with ‘sireno?’
  • Sony developing live-action Barbie comedy
  • California court won’t review Jackson doctor case
  • Business

  • How ‘one percent’ economic elite was uncovered
  • Facebook profits triple as mobile soars
  • Insular Honors Sales Performers at Testimonial Rites
  • Apple increases stock buyback, will split stock
  • Cost-recovery provisions for affected gencos urged
  • Technology

  • Enrile in Masters of the Universe, Lord of the Rings?
  • Top Traits of Digital Marketers
  • No truth to viral no-visa ‘chronicles’
  • ‘Unlimited’ Internet promos not really limitless; lawmakers call for probe
  • Viber releases new design for iPhone, comes to Blackberry 10 for the first time
  • Opinion

  • Editorial cartoon, April 24, 2014
  • Talking to Janet
  • Respite
  • Bucket list
  • JPII in 1981: walking a tightrope
  • Global Nation

  • Obama to visit Filipino soldiers in Fort Bonifacio
  • Fil-Am youth conferences unite under one theme
  • Embassy advisory: Filipinos still need visas to enter US
  • No travel restriction to Mideast, DFA clarifies
  • PH-HK relations repaired, but families of victims still being courted
  • Marketplace